Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
OncoSynergy logo — Physician-founded, patient-focused.

OncoSynergy

Physician-founded, patient-focused.

Founded 2011 United States Stamford, United States 4 employees Growth Total: $9.86M Biotechnology, Health Care +1

General Information

Company Name OncoSynergy
Founded Year 2011
Location United States Stamford, United States
Founders / Decision Makers
Team member Team member
Employees 4
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Growth
Business Model B2B, B2B2C
Revenue Model Licensing, Product Sales, Value Based Pricing
Social

BounceWatch is an independent company data service, not affiliated with OncoSynergy. To contact OncoSynergy, visit oncosynergy.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OncoSynergy compare?

A PDF of OncoSynergy and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OncoSynergy soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OncoSynergy

OncoSynergy, founded in 2011, is a promising biotechnology startup with a compelling vision: "Cancer treatment in one dose." Emerging from UCSF and the JLABS South San Francisco incubator, this Stamford, Connecticut-based company is focused on redefining cancer treatment, particularly for devastating conditions like glioblastoma.

With a small and agile team, OncoSynergy launched its first clinical trial in 2020, targeting aggressive brain cancer. Their ambitious approach aims to maximize patient survival while maintaining quality of life with minimal side effects, reflecting their slogan, "Physician-founded, patient-focused."

The company secured a $3.25M Early VC investment on 01 September 2020 and continues to be at the forefront of innovative cancer research. Investors should note its strategic position near New York City, diverse expertise, and commitment to tackling aggressive cancers, making it a promising candidate for further investment.

Business keywords: biotechnology startup, cancer treatment, oncology, patient-focused, clinical trials, innovation, precision medicine, UCSF spinout, JLABS incubator, glioblastoma, brain cancer, physician-founded, patient advocacy, quality of life, minimizing side effects

Services & Products

development of immunotherapies
clinical trials for cancer treatments
research and development of monoclonal antibodies

Target Customers

oncologists cancer treatment centers patients with solid and hematologic cancers pharmaceutical partners

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Growth Equity VC $6.61M -
01 May 2026
Early VC $3.25M -
01 Sep 2020
Series A Undisclosed 1
Connecticut Innovations
Connecticut Innovations
01 May 2018
Acquisition Undisclosed -
01 Apr 2016
Spinout Undisclosed 1
University of California, San Francisco
01 Jan 2011

OncoSynergy Alternatives & Competitors

View All Alternatives
OncoSynergy vs
Kestrel Therapeutics
Kestrel Therapeutics United States

We aspire to invent brilliant technologies for difficult cancer targets, beginning with mutant RAS

Series A
23 employees
Biopharma, Biotechnology
OncoSynergy vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
OncoSynergy vs
Hemispherian AS
Hemispherian AS Norway

Hemispherian is a biotechnology company developing new treatments for the most aggressive types of c...

Grant
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About OncoSynergy

Physician-founded, patient-focused.
OncoSynergy was founded in 2011.
OncoSynergy is headquartered in Stamford, United States.
OncoSynergy operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biotechnology startup, cancer treatment, oncology and patient-focused. Its customers include oncologists, cancer treatment centers and patients with solid and hematologic cancers.
OncoSynergy has a B2B and B2B2C business model. Its revenue comes from Licensing, Product Sales and Value Based Pricing.
OncoSynergy has approximately 4 employees.
OncoSynergy has completed 5 funding rounds, raising a total of $9.86M. The latest funding stage is Growth.
OncoSynergy offers: development of immunotherapies, clinical trials for cancer treatments, research and development of monoclonal antibodies.
Top alternatives and competitors to OncoSynergy include Kestrel Therapeutics, Synnovation Therapeutics, Hemispherian AS, Puma Biotechnology, Inc., OncoPrecision. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OncoSynergy and Kestrel Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OncoSynergy, https://bouncewatch.com/company/oncosynergy, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout